Cannabis Could Be Rescheduled By Fall, Industry Insider Predicts
“…could be a signal that we’re looking at a September rollout of this”
Two months after President Trump issued an executive order directing his administration to move cannabis from Schedule I to Schedule III, it remains unclear whether the process is underway or when it could be finalized. Meanwhile, the Food and Drug Administration missed a deadline set by Congress to publish a list of known cannabinoids.
So, where does cannabis rescheduling stand?
At the IgniteIt Market Spotlight in New Jersey this month, cannabis industry executives offered sharply different views on the timeline.
Moderator Jeff Guillot, CEO of Guillot Consulting, said he does not expect rescheduling to be completed before fall, citing little visible movement since December and Attorney General Pam Bondi’s decision not to address the issue during recent congressional testimony.
To Read The Rest Of This Article On Green State, Click Here
